164 related articles for article (PubMed ID: 30965065)
1. Lymphopenic community-acquired pneumonia is associated with a dysregulated immune response and increased severity and mortality.
Méndez R; Menéndez R; Amara-Elori I; Feced L; Piró A; Ramírez P; Sempere A; Ortega A; Bermejo-Martín JF; Torres A
J Infect; 2019 Jun; 78(6):423-431. PubMed ID: 30965065
[TBL] [Abstract][Full Text] [Related]
2. Lymphopenic Community Acquired Pneumonia (L-CAP), an Immunological Phenotype Associated with Higher Risk of Mortality.
Bermejo-Martin JF; Cilloniz C; Mendez R; Almansa R; Gabarrus A; Ceccato A; Torres A; Menendez R;
EBioMedicine; 2017 Oct; 24():231-236. PubMed ID: 28958655
[TBL] [Abstract][Full Text] [Related]
3. Cytokine levels predict 30-day mortality in octogenarians and nonagenarians with community-acquired pneumonia: a retrospective observational study.
Pinargote-Celorio H; Miralles G; Cano M; Caparros E; Portilla J; González-Alcaide G; Ramos Rincón JM
Eur J Clin Microbiol Infect Dis; 2020 Feb; 39(2):299-307. PubMed ID: 31758443
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response.
Tejera A; Santolaria F; Diez ML; Alemán-Valls MR; González-Reimers E; Martínez-Riera A; Milena-Abril A
Cytokine; 2007 Jun; 38(3):117-23. PubMed ID: 17659879
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Lymphocyte Subpopulations and Cytokines in COVID-19-Associated Pneumonia and Community-Acquired Pneumonia.
Liu G; Jiang X; Zeng X; Pan Y; Xu H
J Immunol Res; 2021; 2021():6657894. PubMed ID: 34150910
[TBL] [Abstract][Full Text] [Related]
6. The Associations of Serum IL-37 With the Severity and Prognosis in Patients With Community-Acquired Pneumonia: A Retrospective Cohort Study.
Wang JL; Chen X; Xu Y; Chen YX; Wang J; Liu YL; Song HT; Fei J; Zhao H; Fu L
Front Immunol; 2021; 12():636896. PubMed ID: 34025645
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of the characteristics of cellular immune function and its prognostic risk factors in patients with community-acquired pneumonia].
Ding T; Gao L; Zheng L; Ye J; Zhao H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jun; 31(6):684-688. PubMed ID: 31315723
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil-to-Lymphocyte Ratio Improves the Accuracy and Sensitivity of Pneumonia Severity Index in Predicting 30-Day Mortality of CAP Patients.
Zhang HF; Ge YL; Wang HY; Zhang Q; Li WQ; Chen Y; Chen QC; Jin JJ; Xu J; Zhang S; Xu TT; Zhang X; Yu HL; Zhu XY; Liu CH; Bai J; Zhang JB; Xie BQ; Wang Y; Fu AS; Zhang PP
Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625349
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort.
Ito A; Ishida T; Tokumasu H; Washio Y; Yamazaki A; Ito Y; Tachibana H
BMC Pulm Med; 2017 May; 17(1):78. PubMed ID: 28464807
[TBL] [Abstract][Full Text] [Related]
10. The effect of age on the systemic inflammatory response in patients with community-acquired pneumonia.
van Vught LA; Endeman H; Meijvis SC; Zwinderman AH; Scicluna BP; Biesma DH; van der Poll T
Clin Microbiol Infect; 2014 Nov; 20(11):1183-8. PubMed ID: 24930498
[TBL] [Abstract][Full Text] [Related]
11. [Immunocompetent adults hospitalized for a community-acquired pneumonia: Serum C-reactive protein as a prognostic marker].
Saldías-Peñafiel F; Salinas-Rossel G; Farcas-Oksenberg K; Reyes-Sánchez A; Díaz-Patiño O
Rev Med Chil; 2019 Aug; 147(8):983-992. PubMed ID: 31859962
[TBL] [Abstract][Full Text] [Related]
12. Mortality prediction to hospitalized patients with influenza pneumonia: PO
Shi SJ; Li H; Liu M; Liu YM; Zhou F; Liu B; Qu JX; Cao B
Clin Respir J; 2017 May; 11(3):352-360. PubMed ID: 26148709
[TBL] [Abstract][Full Text] [Related]
13. CURB-65 and other markers of illness severity in community-acquired pneumonia among HIV-positive patients.
Almeida A; Almeida AR; Castelo Branco S; Vesza Z; Pereira R
Int J STD AIDS; 2016 Oct; 27(11):998-1004. PubMed ID: 26394997
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte subset counts during the course of community-acquired pneumonia: evolution according to age, human immunodeficiency virus status, and etiologic microorganisms.
Fantin B; Joly V; Elbim C; Golmard JL; Gougerot-Pocidalo MA; Yeni P; Carbon C
Clin Infect Dis; 1996 Jun; 22(6):1096-8. PubMed ID: 8783719
[TBL] [Abstract][Full Text] [Related]
15. IgG2 as an independent risk factor for mortality in patients with community-acquired pneumonia.
de la Torre MC; Palomera E; Serra-Prat M; Güell E; Yébenes JC; Bermejo-Martín JF; Almirall J
J Crit Care; 2016 Oct; 35():115-9. PubMed ID: 27481745
[TBL] [Abstract][Full Text] [Related]
16. Effects of systemic steroids in patients with severe community-acquired pneumonia.
Garcia-Vidal C; Calbo E; Pascual V; Ferrer C; Quintana S; Garau J
Eur Respir J; 2007 Nov; 30(5):951-6. PubMed ID: 17690125
[TBL] [Abstract][Full Text] [Related]
17. T helper 17 cells are involved in the local and systemic inflammatory response in community-acquired pneumonia.
Paats MS; Bergen IM; Hanselaar WE; van Zoelen EC; Verbrugh HA; Hoogsteden HC; van den Blink B; Hendriks RW; van der Eerden MM
Thorax; 2013 May; 68(5):468-74. PubMed ID: 23315492
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulins concentration and B cell counts as severity markers in adult community-acquired pneumonia: Cross sectional study.
Luchsinger V; Lizama L; Garmendia ML; Tempio F; Ruiz M; Pizarro R; Rossi P; Huenchur L; Moreno C; López M; Ampuero S; Larrañaga C; Avendaño LF
Medicine (Baltimore); 2020 Nov; 99(45):e22390. PubMed ID: 33157914
[TBL] [Abstract][Full Text] [Related]
19. Expression Levels of Interferon Regulatory Factor 5 (IRF5) and Related Inflammatory Cytokines Associated with Severity, Prognosis, and Causative Pathogen in Patients with Community-Acquired Pneumonia.
Wang X; Guo J; Wang Y; Xiao Y; Wang L; Hua S
Med Sci Monit; 2018 May; 24():3620-3630. PubMed ID: 29847542
[TBL] [Abstract][Full Text] [Related]
20. Effects of age and comorbidities on serum levels of inflammatory markers in community-acquired pneumonia.
Viasus D; Simonetti AF; Estupiñan-Bohórquez AF; Carratalà J
Eur J Clin Invest; 2021 Jun; 51(6):e13480. PubMed ID: 33350464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
